Skip to main content

Effect of Teledermatologist Supervision in AI Skin Cancer Apps on Patients' Trust and Adherence Intentions: Randomized Controlled Trial

In brief

Dermatologist-supervised skin app advice raised trust 12 points and adherence intent

In an online experiment with 879 Dutch adults, advice combining AI and teledermatologist oversight scored 12 points higher for trust than AI-only advice, and participants had 1.7 times the odds of intending to follow it. These were responses to simulated scenarios, not real app use, so whether oversight changes actual care-seeking remains unknown.

Journal
JMIR mHealth and uHealth (Q1)
Published
17 November 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Ritwik Swain, Mihaela Masic, Justine Staal, Natalie Dangerman, Elise Barendse, Marlies Wakkee, et al.
PMID
43044097
DOI
10.2196/93991

Why clinicians should know about it

  • Picked for Dermatology (top studies of the week, 22 November 2026): Randomized evaluation of AI-assisted skin cancer advice and patient adherence

Abstract

BACKGROUND: Skin cancer incidence is rising globally, increasing pressure on dermatology services and making efficient triage increasingly important. AI-driven skin cancer mobile health apps may help address this need, but their usefulness depends on whether users trust the advice and intend to follow it. Teledermatologist supervision has been proposed to combine AI efficiency with human clinical oversight, but dermatologist shortages make it critical to understand whether such supervision improves patient trust and adherence at the population level, or whether AI-only advice suffices for most users. OBJECTIVE: This study tests whether teledermatologist supervision in an AI-driven skin cancer app affects patient trust and adherence intentions, compared with AI-only advice, and whether these effects differ by motivational context and risk assessment level. METHODS: The randomized controlled, online vignette experiment with repeated measures was conducted from May to June 2025 as a single-center study among Dutch adults via an academic hospital-based patient panel. Eligible participants were adult members of the Erasmus MC Digital Patient Panel invited by email; those not completing all 4 vignette trials were excluded from the analysis. Participants completed 4 simulated mobile app scenarios varying in advice source (AI-only vs hybrid teledermatologist and AI) and risk assessment level (high vs low). The primary outcomes were trust in the advice (0-100 scale) and adherence intention (recoded 3-level ordinal scale). Mixed-effects models were used to analyze the data. RESULTS: Of the 2707 patient panel members, 879 participated (response rate: 32.5%). Participants were aged 18 to 93 (mean 62.5, SD 12.64) years; 50.4% (n=443) were female, and 21.4% (n=188) had a history of skin cancer. Participants were randomly allocated to motivation conditions (concern: n=438 vs curiosity: n=441). Trust was higher for hybrid advice than AI-only advice (mean 76.9, SE 0.73 vs mean 65.7, SE 0.73; estimated difference 11.98; partial η²=0.22; P<.001). The odds of adherence were 1.7 times greater with hybrid vs AI-only (odds ratio 1/0.59=1.7, 95% CI 1.28-2.22; P<.001). High-risk assessments increased adherence (odds ratio 2.9, 95% CI 2.2-3.8; P<.001), with a moderated effect by motivation (P=.03), showing stronger adherence with concern vs curiosity. The effect of advice source on adherence was fully mediated by trust. CONCLUSIONS: Teledermatologist supervision of AI-based advice robustly increased patient trust and adherence intentions, particularly for high-risk assessments and concerned users. Our experiment is innovative in testing teledermatologist supervision in a population-level AI skin cancer app and in examining how motivational context shapes responses to advice. Unlike studies focused on postreferral teledermatology or chatbot-based advice, this study isolates the effect of hybrid AI-human advice in a store-and-forward screening context. These findings suggest that developers and health care implementers may consider integrating teledermatologist supervision to maximize patient trust of and adherence to advice, potentially improving triaging efficiency and safety.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.